Cargando…

Imatinib-Induced Psoriasis

Detalles Bibliográficos
Autores principales:	Atalay, Figen, Kızılkılıç, Ebru, Ada, R. Simin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2013
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878456/ https://www.ncbi.nlm.nih.gov/pubmed/24385791 http://dx.doi.org/10.4274/Tjh.2012.0147

Ejemplares similares

Exacerbation of Psoriasis after Imatinib Mesylate Treatment
por: Shim, Joon Ho, et al.
Publicado: (2016)

Imatinib-induced Gynecomastia
por: Gupta, Pragya, et al.
Publicado: (2019)

Eyebrow Whitening Induced by Imatinib
por: Yavasoglu, Irfan, et al.
Publicado: (2020)

Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib
por: Lee, Min Kyung, et al.
Publicado: (2015)

Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
por: Song, Hyo Sang, et al.
Publicado: (2014)

Plantar Keratoderma with Pachyonychia Likely Induced by Imatinib Mesylate
por: Kim, Hyung Ok, et al.
Publicado: (2013)

Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor
por: Wang, Gang, et al.
Publicado: (2021)

Etanercept in the Treatment of Generalized Annular Pustular Psoriasis
por: Lo Schiavo, Ada, et al.
Publicado: (2012)

Reply: The long-term response to imatinib treatment of CML
por: Michor, F
Publicado: (2007)

Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report - Is there an Association with the COVID-19 Vaccine?
por: Kizilkilic, Esra Kochan, et al.
Publicado: (2023)

Imatinib plasma levels: correlation with clinical benefit in GIST patients
por: Widmer, N, et al.
Publicado: (2010)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection
por: Lee, Na-Ri, et al.
Publicado: (2015)

Chlorambucil-induced psoriasis: A rare entity
por: Kumar, Sumir, et al.
Publicado: (2020)

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells
por: Zeng, Chengwu, et al.
Publicado: (2018)

Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection
por: Luo, Zhuan-Bo, et al.
Publicado: (2017)

Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
por: Lee, Jae-Hyung, et al.
Publicado: (2013)

Gynecomastia in a Boy with Chronic Myeloid Leukemia during Imatinib Therapy
por: Tavil, Betül, et al.
Publicado: (2013)

UVB-induced bullous pemphigoid in a patient with psoriasis
por: Ceryn, Justyna, et al.
Publicado: (2020)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2014)

Early clinical experience with imatinib in COVID-19: Searching for a dual effect
por: Morales-Ortega, Alejandro, et al.
Publicado: (2021)

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
por: Mosakhani, Neda, et al.
Publicado: (2013)

Drug-related psoriasis
por: Ganeva, Maria, et al.
Publicado: (2023)

GASTROINTESTINAL STROMAL TUMOR OF THE RECTUM TREATED WITH NEOADJUVANT IMATINIB FOLLOWED BY TRANSANAL ENDOSCOPIC MICROSURGERY
por: NAHAS, Caio Sergio Rizkallah, et al.
Publicado: (2015)

Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction
por: Kumar, Meet, et al.
Publicado: (2014)

Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells
por: Regev, Ofer, et al.
Publicado: (2020)

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
por: Zámečníkova, Adriana
Publicado: (2011)

Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance
por: Cao, Jie, et al.
Publicado: (2018)

Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022)

Psoriasis and tuberculosis binomial distribution?
por: Chiriac, Anca, et al.
Publicado: (2014)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)

A Study of Itch in Psoriasis
por: Meena, Manju, et al.
Publicado: (2021)

Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor
por: Yim, Eunjung, et al.
Publicado: (2018)

Variant Analysis of CARD14 in a Chinese Han Population with Psoriasis Vulgaris and Generalized Pustular Psoriasis
por: Qin, Peipei, et al.
Publicado: (2014)

Comment on “occupational psoriasis after exposure to rockwool”
por: Koch, Christoph, et al.
Publicado: (2021)

De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine()
por: Zaiem, Ahmed, et al.
Publicado: (2022)

Polymorphic pityriasis rosea precipitating psoriasis
por: Sacchidanand, Sarvajnamurthy, et al.
Publicado: (2013)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

Linear psoriasis: A rare presentation
por: Singh, Nidhi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iecsjlh29n4a7nb6nklir2j282